NeuroSense Therapeutics Ltd. (NRSN) stock
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.28+0.02 (+1.59%)
Close on Nov 20, 2026Market cap $2.35MP/E –Yield –
NeuroSense Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
NeuroSense Therapeutics's price to book ratio was 16.2× on Jul 31, 2025, against 2.6× a year earlier. Over the last 2 years it ranged from 0.0× to 17.0×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 16.2× | +16.1 |
| 2024 | Jan 31, 2024 | 0.1× | +0.0 |
| 2023 | Dec 29, 2023 | 0.1× | −0.3 |
| 2022 | Jul 29, 2022 | 0.3× | – |
See a number that looks wrong?